JPWO2022250142A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022250142A5 JPWO2022250142A5 JP2023524251A JP2023524251A JPWO2022250142A5 JP WO2022250142 A5 JPWO2022250142 A5 JP WO2022250142A5 JP 2023524251 A JP2023524251 A JP 2023524251A JP 2023524251 A JP2023524251 A JP 2023524251A JP WO2022250142 A5 JPWO2022250142 A5 JP WO2022250142A5
- Authority
- JP
- Japan
- Prior art keywords
- collection container
- blood collection
- blood
- container according
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 claims 39
- 210000004369 blood Anatomy 0.000 claims 39
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 16
- 239000000377 silicon dioxide Substances 0.000 claims 8
- 238000000926 separation method Methods 0.000 claims 7
- 239000007864 aqueous solution Substances 0.000 claims 6
- 239000000843 powder Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 4
- 239000011347 resin Substances 0.000 claims 4
- 229920005989 resin Polymers 0.000 claims 4
- 239000003146 anticoagulant agent Substances 0.000 claims 3
- 229940127219 anticoagulant drug Drugs 0.000 claims 3
- 150000001720 carbohydrates Chemical class 0.000 claims 3
- 230000005484 gravity Effects 0.000 claims 3
- 229910017053 inorganic salt Inorganic materials 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 2
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 claims 2
- 229960002897 heparin Drugs 0.000 claims 2
- 229920000669 heparin Polymers 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 239000002504 physiological saline solution Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 1
- 239000004925 Acrylic resin Substances 0.000 claims 1
- 229920000178 Acrylic resin Polymers 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 239000003208 petroleum Substances 0.000 claims 1
- 229920001225 polyester resin Polymers 0.000 claims 1
- 239000004645 polyester resin Substances 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021090433 | 2021-05-28 | ||
| JP2021090433 | 2021-05-28 | ||
| PCT/JP2022/021743 WO2022250142A1 (ja) | 2021-05-28 | 2022-05-27 | 血液採取容器、血漿の分離方法、細胞外遊離核酸の分離方法及び細胞外小胞の分離方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022250142A1 JPWO2022250142A1 (cg-RX-API-DMAC7.html) | 2022-12-01 |
| JPWO2022250142A5 true JPWO2022250142A5 (cg-RX-API-DMAC7.html) | 2023-11-01 |
| JP7601359B2 JP7601359B2 (ja) | 2024-12-17 |
Family
ID=84228957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524251A Active JP7601359B2 (ja) | 2021-05-28 | 2022-05-27 | 血液採取容器、血漿の分離方法、細胞外遊離核酸の分離方法及び細胞外小胞の分離方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240245844A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4350348A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7601359B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240013088A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117413181A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3218292A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022250142A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024204675A1 (cg-RX-API-DMAC7.html) * | 2023-03-29 | 2024-10-03 | ||
| JP7670408B1 (ja) * | 2024-03-22 | 2025-04-30 | 積水メディカル株式会社 | 血液採取容器 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4260303B2 (ja) * | 1999-09-09 | 2009-04-30 | 旭化成ファーマ株式会社 | 血液処理方法および組成物 |
| JP4163056B2 (ja) | 2003-06-27 | 2008-10-08 | 株式会社エスアールエル | 血中インスリン濃度測定用添加剤組成物及びそれを含む採血管 |
| EP2360470A4 (en) * | 2008-11-07 | 2013-01-02 | Hitachi Chemical Co Ltd | BLOOD SERUM OR BLOOD PLASMA SEPARATOR MATERIAL AND BLOOD COLLECTION TUBE USING THE SAME |
| EP2923765B1 (en) | 2009-05-15 | 2021-03-17 | Becton, Dickinson and Company | Density phase separation device |
| WO2013111130A1 (en) * | 2012-01-23 | 2013-08-01 | Estar Technologies Ltd | A system and method for obtaining a cellular sample enriched with defined cells such as platelet rich plasma(prp) |
| GB201421013D0 (en) * | 2014-11-26 | 2015-01-07 | Turzi Antoine | New standardizations & medical devices for the preparation of platelet rich plasma (PRP) or bone marrow centrate (BMC) |
| WO2016159236A1 (ja) | 2015-03-31 | 2016-10-06 | 積水メディカル株式会社 | 血清または血漿分離用組成物、並びに血液採取容器 |
| US11252955B2 (en) * | 2015-06-01 | 2022-02-22 | Fenwal, Inc. | System for washing red blood cells to reduce hemolysis |
| CA3024996A1 (en) * | 2016-06-08 | 2017-12-14 | Cf Genome, Llc | A chemical composition to stabilize extracellular vesicles in a blood sample and method of use thereof |
| JP7293244B2 (ja) | 2017-10-19 | 2023-06-19 | ストレック, インコーポレイテッド | 溶血、凝固調節および細胞外小胞の安定化のための組成物 |
| CN109266531A (zh) * | 2018-10-08 | 2019-01-25 | 陈琼娣 | 一种外周血单个核细胞分离管及其制备方法 |
| US20200196594A1 (en) * | 2018-12-24 | 2020-06-25 | deltaDNA Biosciences Inc. | Composition and method for segregating extracellular dna in blood |
| US20210146029A1 (en) * | 2019-11-19 | 2021-05-20 | Immunicom, Inc. | System and method for removal of immune inhibitors from biological fluids |
-
2022
- 2022-05-27 KR KR1020237032624A patent/KR20240013088A/ko active Pending
- 2022-05-27 CN CN202280038108.2A patent/CN117413181A/zh active Pending
- 2022-05-27 US US18/564,326 patent/US20240245844A1/en active Pending
- 2022-05-27 EP EP22811410.4A patent/EP4350348A4/en active Pending
- 2022-05-27 JP JP2023524251A patent/JP7601359B2/ja active Active
- 2022-05-27 WO PCT/JP2022/021743 patent/WO2022250142A1/ja not_active Ceased
- 2022-05-27 CA CA3218292A patent/CA3218292A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6905612B2 (en) | Plasma concentrate apparatus and method | |
| Högman et al. | Red cell preservation in protein-poor media | |
| US4111199A (en) | Method of collecting transfusable granulocytes by gravity leukopheresis | |
| JPH083484B2 (ja) | 血液サンプルの細胞成分を分離する改良方法 | |
| ES8203224A1 (es) | Procedimiento de preparacion de globulos rojos concentrados para almacenamiento. | |
| Waters | Intraoperative blood recovery | |
| JPS603367B2 (ja) | 白血球分離法および白血球分離材 | |
| JP2017518997A (ja) | 周囲温度における血小板の安定化 | |
| JP2002503250A (ja) | 血小板懸濁物および血小板を再懸濁するための方法 | |
| JP2012506901A5 (cg-RX-API-DMAC7.html) | ||
| JP6827048B2 (ja) | 赤血球沈降速度の低下 | |
| JPWO2023145137A5 (cg-RX-API-DMAC7.html) | ||
| WO2022239870A1 (ja) | 血液由来成長因子含有組成物及びその調製方法 | |
| CH645190A5 (fr) | Procede et ensemble pour le marquage des globules rouges du sang avec du technetium-99. | |
| WO1988005331A1 (en) | Blood cell separation | |
| WO2022250142A1 (ja) | 血液採取容器、血漿の分離方法、細胞外遊離核酸の分離方法及び細胞外小胞の分離方法 | |
| Remley et al. | Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products | |
| JPWO2023181468A5 (cg-RX-API-DMAC7.html) | ||
| Sussman et al. | Harvesting of granulocytes using a hydroxyethyl starch solution | |
| JP2008231095A (ja) | 沈降速度を調整する方法 | |
| Garg et al. | Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis | |
| CN107058221A (zh) | 一种鲟鱼外周血淋巴细胞的分离方法 | |
| JP3065728B2 (ja) | 単核球分離管および単核球分離方法 | |
| JPWO2025197904A5 (cg-RX-API-DMAC7.html) | ||
| US20020084221A1 (en) | Method for precipitating red blood cells |